Camas, Katherine P.
HRN: 22-97-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFUROXIME 1.5GM (VIAL)
05/29/2023
05/31/2023
IVTT
1.5g
Q8 X 3 Doses
Sp Tabhso
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes